title: The role of litigation in defining drug risks.
authors.affiliation: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA. akesselheim@partners.org
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
authors.forename: Jerry
authors.initials: J
authors.lastname: Avorn
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D064420:Drug-Related Side Effects and Adverse Reactions; D006291:Health Policy; D006801:Humans; D007880:Legislation, Drug; D016365:Liability, Legal; D014481:United States; D014486:United States Food and Drug Administration